Search results
Showing 1 to 2 of 2 results for ta611
Evidence-based recommendations on rucaparib (Rubraca) for treating relapsed platinum-sensitive ovarian, fallopian tube or primary peritoneal cancer that has responded to platinum-based chemotherapy in adults.
In development [GID-TA10985] Expected publication date: 12 June 2024